An invasive strategy is associated with decreased mortality in patients 80 years and older with acute myocardial infarction

American Journal of Geriatric Cardiology

Volumn 16, Issue 2, 2007, Pages 84-91

  Schloss, Timothy W ^a   Gage, Brian F ^a   Rich, Michael W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

AGED; AORTA BALLOON; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVOR; TREATMENT OUTCOME;

AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVORS; TREATMENT OUTCOME;

EID: 34248211225     PISSN: 10767460     EISSN: 1751715X     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2007.05775.x     Document Type: Article

References (26)

1. Goldberg RJ, McCormick D, Gurwitz JH, et al. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol. 1998;82:1311-1317.
2. Singh M, Matthew V, Garratt KN, et al. Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic. Am J Med. 2000;108:187-192.
3. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001;286:708-713.
4. Berger AK, Radford MJ, Wang Y, et al. Thrombolytic therapy in older patients. J Am Coll Cardiol. 2000;36:366-374.
5. Thiemann DR, Coresh J, Schulman SP, et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2000;101:2239-2246.
6. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. J Am Coll Cardiol. 2000;36:723-730.
7. Berger AK, Schulman KA, Gersh BJ, et al. Primary coronary angioplasty vs. thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA. 1999;282:341-348.
8. de Boer MJ, Ottervanger JP, van't Hof AW, et al, for the Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723-1728.
9. Curb JD, Ford CE, Pressel S, et al. Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol. 1985;121:754-766.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
11. Cox D. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
12. Cannon CP, Weintraub WS, Demopoulos LA, et al, for the TACTICS-TIMI 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
13. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicenter study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet. 1999;354:708-715.
14. Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000;356:9-16.
15. Lagerqvist B, Husted S, Kontny F, et al, for the Fast Revascularization during InStability in Coronary artery disease II investigators. A long-term perspective on the protective effects of an early invasive strategy in unstablecoronary artery disease: two- year follow-up of the FRISC-II invasive study. J Am Coll Cardiol. 2002;40:1902-1914.
16. Fox KA, Poole-Wilson PA, Henderson RA, et al, for the Randomized Intervention Trial of Unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet. 2002;360:743-751.
17. Spacek R, Widimsky P, Straka Z, et al. Value of first day angiography/ angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. Eur Heart J. 2002;23:230-238.
18. Michalis LK, Stroumbis CS, Pappas K, et al. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study). Eur Heart J. 2000;21:1954-1959.
19. Minai K, Horie H, Takahashi M, et al. Long-term outcome of primary percutaneous transluminal coronary angioplasty for low-risk acute myocardial infarction in patients older than 80 years: a single-center, open, randomized trial. Am Heart J. 2002;143:497-505.
20. DeGeare VS, Grines C.L. Primary percutaneous intervention in octogenarians with acute myocardial infarction: the treatment of choice. Am J Med. 2000;108:257-258.
21. Kroll CR, Ohman E.M. Should reperfusion strategies in myocardial infarction be modified for the very elderly? Am Heart J. 2002;143:373-376.
22. Anderson HV, Cannon CP, Stone PH, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIb clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995;26:1643-1650.
23. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med. 2004;141:186-195.
24. Radford MJ, Foody J.M. How do observational studies expand the evidence base for therapy? JAMA. 2001;286:1228-1230.
25. Rosenbaum P.R. Discussing hidden bias in observational studies. Ann Intern Med. 1991;115:901-905.
26. Braitman LE, Rosenbaum PR. Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med. 2002;137:693-695.